Cargando…

1299. In Vitro-In Vivo Discordance with β-lactams against Metallo-β-lactamase-Producing Enterobacterales: Implications for Susceptibility Testing

BACKGROUND: Using murine models of thigh and lung infection, we previously reported the potent in vivo activity of carbapenem human-simulated regimens against metallo-β-lactamase-producing Enterobacterales despite the observed resistance in vitro (JAC 2020 Apr 1;75(4):997-1005, AAC 2014;58(3):1671-7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelraouf, Kamilia, Reyes, Sergio, Nicolau, David P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777513/ http://dx.doi.org/10.1093/ofid/ofaa439.1482

Ejemplares similares

1650. Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap
por: Abdelraouf, Kamilia, et al.
Publicado: (2022)

1312. Metallo-β-lactamase-Producing Enterobacterales (MBL-EB): Is it Time to Rethink Our Assessment Tools?
por: Abdelraouf, Kamilia, et al.
Publicado: (2020)

1533. Is Cation-Adjusted Mueller–Hinton Broth (CAMHB) Appropriate for Metallo-β-lactamase (MBL) Susceptibility Testing? Novel Insights in In Vitro–In Vivo Discordance Among MBL-Producing Enterobacteriaceae
por: Asempa, Tomefa E, et al.
Publicado: (2019)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales
por: Tan, Xing, et al.
Publicado: (2021)

In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales
por: Peters, Byron K., et al.
Publicado: (2023)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
Publicado: (2021)

New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria
por: Yao, Yancheng, et al.
Publicado: (2022)

Plasmid analysis of NDM metallo-β-lactamase-producing Enterobacterales isolated in Vietnam
por: Hirabayashi, Aki, et al.
Publicado: (2021)

New Delhi Metallo-β-Lactamase–Producing Enterobacterales Bacteria, Switzerland, 2019–2020
por: Findlay, Jacqueline, et al.
Publicado: (2021)

1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases
por: Lindley, Jill, et al.
Publicado: (2021)

In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model
por: Abdelraouf, Kamilia, et al.
Publicado: (2023)

Time-resolved β-lactam cleavage by L1 metallo-β-lactamase
por: Wilamowski, M., et al.
Publicado: (2022)

Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors
por: Shungube, Mbongeni, et al.
Publicado: (2023)

In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
por: Wang, Wen, et al.
Publicado: (2021)

1245. In Vivo Efficacy of WCK 4282 (High Dose Cefepime [FEP]-Tazobactam [TZB]) Against β-Lactamase-Producing (BLP) Gram-Negative Bacteria in a Neutropenic Murine Pneumonia Model
por: Lasko, Maxwell J, et al.
Publicado: (2020)

Evaluation of Metallo-β-Lactamase Susceptibility Testing in a Physiologic Medium
por: Asempa, Tomefa E., et al.
Publicado: (2021)

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Producing Enterobacterales Urinary Tract Infections
por: Anderson, Daniel T, et al.
Publicado: (2022)

682. In Vivo Pharmacodynamics of VNRX-7145 in the Neutropenic Murine Thigh Infection Model When Administered in Combination with Humanized Exposures of Twice Daily Ceftibuten (CTB) Against Serine β-Lactamase-Producing Enterobacteriaceae (SBL-EB)
por: Avery, Lindsay M, et al.
Publicado: (2019)

In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales
por: Lomovskaya, Olga, et al.
Publicado: (2023)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing
por: Lo, Stéphane, et al.
Publicado: (2022)

Characterization and Public Health Insights of the New Delhi Metallo-β-Lactamase-Producing Enterobacterales from Laying Hens in China
por: Wei, Hongcheng, et al.
Publicado: (2022)

Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors
por: Reddy, Nakita, et al.
Publicado: (2023)

Evaluation of the VITEK2 AST-XN17 card for the detection of carbapenemase-producing Enterobacterales in isolates primarily producing metallo β-lactamase
por: Kuchibiro, Tomokazu, et al.
Publicado: (2022)

1405. Efficacy of the Human-Simulated Regimen (HSR) of Cefepime (FEP)/VNRX-5133 Combination Against Serine β-Lactamase-Producing Gram-negative Bacteria in the Neutropenic Murine Thigh Infection Model
por: Abdelraouf, Kamilia, et al.
Publicado: (2018)

1279. In Vitro Activity of Nacubactam (OP0595) Alone and in Combination with β-Lactams against β-Lactamase-Producing Enterobacterales Isolated in Japan
por: Nagira, Yu, et al.
Publicado: (2020)

Tigecycline activity against metallo-β-lactamase-producing bacteria
por: Kumar, Simit, et al.
Publicado: (2013)

Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea
por: Hong, Jun Sung, et al.
Publicado: (2015)

Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
por: Hong, Duck Jin, et al.
Publicado: (2015)

Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae
por: Serio, Alisa W, et al.
Publicado: (2019)

1368. Assessment of the In Vivo Efficacy of Human-Simulated Epithelial Lining Fluid (ELF) Exposure of Meropenem/Nacubactam (MEM/NAC) Combination Against β-Lactamase-Producing Enterobacteriaceae in Neutropenic Lung Infection Model
por: Asempa, Tomefa E, et al.
Publicado: (2018)

Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak
por: Falcone, Marco, et al.
Publicado: (2020)

Theaflavin‐3,3´‐digallate increases the antibacterial activity of β‐lactam antibiotics by inhibiting metallo‐β‐lactamase activity
por: Teng, Zihao, et al.
Publicado: (2019)

Metallo-β-lactamases immobilized by magnetic zeolitic imidazolate frameworks-8 for degradation of β-lactam antibiotics in an aqueous environment
por: Wang, Quanfang, et al.
Publicado: (2023)

Semi-rational screening of the inhibitors and β-lactam antibiotics against the New Delhi metallo-β-lactamase 1 (NDM-1) producing E. coli
por: Wang, Juan, et al.
Publicado: (2018)

2747. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-β-Lactamase-Producing Enterobacterales collected through the Antimicrobial Resistance Laboratory Network, March 2019 to April 2023
por: Bhatnagar, Amelia, et al.
Publicado: (2023)

The Mechanisms of Catalysis by Metallo β-Lactamases
por: Page, Michael I., et al.
Publicado: (2008)

New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae, United States
por: Rasheed, J. Kamile, et al.
Publicado: (2013)

Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States Children
por: Logan, Latania K., et al.
Publicado: (2016)

Descriptive analysis of infections due to New Delhi metallo-β-lactamase-producing Enterobacterales in children at Red Cross War Memorial Children’s Hospital
por: Greybe, Leonore, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8li1eh5jgrvtat1gd23fggs6m6